News
Nonsteroidal MRAs Reduce Kidney, Cardiovascular Risks
The systematic review and meta-analysis included a broad range of patients with and without chronic kidney disease.
Hemoglobin levels lower, erythropoietin stimulating agent use higher, even for water lead levels below EPA threshold for regulatory action